News

ESC is pleased to endorse the 2nd Global Cardiovascular Forum in St. Petersburg in 2014

29.08.20132899

Professor Komajda is pleased to inform that Prs. Jeroen Bax and Alex Vahanian have accepted the endorsement by ESC of the 2nd Global Cardiovascular Forum in St. Petersburg in 2014.

Uric acid and risk of heart failure: a systematic review and meta-analysis

29.08.20132047

We aimed to perform a systematic review and meta-analysis to assess the association between serum uric acid and incident heart failure (HF)/prognosis of HF patients.

The 6-minute walking test and all-cause mortality in patients undergoing a post-cardiac surgery rehabilitation program

28.08.20131742

The 6-minute walking test (6mWT) is used to prescribe physical activity in cardiac surgery patients. The clinical value of a pre-discharge 6mWT and its association with outcome is not well defined.

Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure

27.08.20131843

We examined whether the severity of central sleep apnoea (CSA) and the level of C-reactive protein are associated with the prevalence and complexity of arrhythmias, and whether these factors contribute to increased risk of nocturnal sudden death.

Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis

26.08.20131773

Nonalcoholic fatty liver disease (NAFLD) is closely correlated with insulin resistance and several metabolic syndrome features, but whether it could increase the risk of cardiovascular disease remains undefined.

Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis

23.08.20131958

To assess long-term outcomes and the management of critical left-sided infective endocarditis (IE) and evaluate the impact of surgery.

Beyond Medication Prescription as Performance Measures: Optimal Secondary Prevention Medication Dosing After AMI ONLINE FIRST

22.08.20131866

To examine the prescribing patterns of medications quantified by the performance measures for acute myocardial infarction (AMI).